How to manage bleeding post-Transurethral Resection of the Prostate (TURP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Post-TURP Bleeding

Immediate management of post-TURP bleeding requires continuous bladder irrigation with a large-caliber urethral catheter (20-24 Fr), and if conservative measures fail, proceed directly to endoscopic intervention with fulguration of bleeding vessels, reserving arterial embolization or open prostatic packing for refractory cases. 1, 2, 3

Initial Conservative Management

  • Place or upsize to a large-caliber three-way urethral catheter (20-24 Fr) immediately to enable continuous bladder irrigation and prevent clot retention 2, 3
  • Initiate continuous bladder irrigation with normal saline to maintain clear or light pink effluent and prevent catheter obstruction by blood clots 3, 4
  • Apply gentle traction on the catheter for 15-30 minutes to compress the prostatic fossa against the bladder neck, which can tamponade venous bleeding 3
  • Correct any underlying coagulation defects including thrombocytopenia, coagulopathy, or anticoagulation reversal if applicable 5, 6
  • Monitor hemodynamic status closely with serial vital signs and hemoglobin measurements to detect ongoing blood loss 3, 4

Timing and Severity Assessment

Early bleeding (first 24-48 hours) is typically due to inadequate hemostasis or capsular perforation rather than fibrinolysis, requiring mechanical or surgical intervention 7

Delayed bleeding (7-14 days post-surgery) may occur as eschar sloughs from the prostatic fossa and can be managed similarly to early bleeding 3

Endoscopic Intervention

If conservative measures fail within 2-4 hours or the patient becomes hemodynamically unstable, proceed immediately to cystoscopy with fulguration 3

  • Return to the operating room for cystoscopy under anesthesia to identify and fulgurate specific bleeding vessels in the prostatic fossa 3
  • Use monopolar or bipolar electrocautery to achieve hemostasis of identifiable bleeding points 3
  • Evacuate clots from the bladder to improve visualization and prevent bladder distention 3
  • This endoscopic approach successfully controls bleeding in approximately 95% of cases requiring intervention 3

Advanced Interventions for Refractory Bleeding

Arterial Embolization

For patients who fail endoscopic management or are poor surgical candidates, superselective arterial embolization is the next step 5

  • Perform angiography to identify the bleeding prostatic artery (typically branches of the internal iliac artery) 5
  • Superselective embolization can achieve hemostasis while preserving bladder and rectal blood supply 5
  • This is particularly useful in patients with significant comorbidities who cannot tolerate repeat surgery 5
  • Success rates approach 90-95% when performed by experienced interventional radiologists 5

Open Prostatic Packing

When both endoscopic management and embolization fail or are unavailable, open exploration with prostatic packing is life-saving 3

  • Perform a suprapubic cystotomy to access the prostatic fossa 3
  • Pack the prostatic cavity tightly with gauze or hemostatic agents to achieve tamponade 3
  • Leave packing in place for 24-48 hours before removal under controlled conditions 3
  • This technique is reserved for life-threatening hemorrhage but can be definitive when other measures fail 3

Special Considerations for Anticoagulated Patients

Patients on chronic anticoagulation have higher bleeding risk but can be managed successfully with careful perioperative planning 1, 6

  • Patients on warfarin should be bridged with LMWH perioperatively, with LMWH held 24 hours before surgery and resumed at least 24 hours postoperatively or when bleeding has subsided 1
  • Delay resumption of anticoagulation by 24-48 hours if any concern for ongoing bleeding exists 1, 6
  • The risk of VTE (including DVT) is relatively low (19.4% superficial venous thrombosis, with only some progressing to DVT) compared to bleeding risk in the immediate postoperative period 6
  • Patients on antiplatelet therapy (aspirin) have only modestly increased minor bleeding without significantly increased transfusion requirements 1

Pharmacologic Adjuncts

Intravesical aminocaproic acid (0.5%) may be considered for delayed recurrent bleeding thought to be due to fibrinolysis, though it has limited efficacy for early post-TURP bleeding 7

  • Early post-TURP bleeding is mechanical, not fibrinolytic, so antifibrinolytic agents are generally ineffective in the first 72 hours 7
  • Systemic antifibrinolytics are not recommended due to thromboembolic risk without proven benefit 7

Transfusion Thresholds

Transfuse packed red blood cells for hemoglobin <7 g/dL in stable patients or <8 g/dL in patients with cardiovascular disease or ongoing bleeding 4

  • TURP and TURBT are not considered high-risk bleeding procedures in contemporary practice, with major bleeding rates <5% 4
  • Most postoperative anemia resolves without transfusion with conservative management 4

Common Pitfalls to Avoid

  • Do not delay endoscopic intervention if conservative measures fail within 2-4 hours, as continued bleeding leads to clot retention and bladder distention 3
  • Do not restart anticoagulation too early (before 24 hours) as this coincides with peak bleeding risk and transfusion requirements 1, 6
  • Do not use small-caliber catheters (<20 Fr) as they cannot accommodate adequate irrigation and are prone to clot obstruction 2, 3
  • Do not attribute all bleeding to coagulopathy—most cases are due to inadequate surgical hemostasis or capsular perforation requiring mechanical intervention 5, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.